Articles with public access mandates - Didier Raoult - Agence Nationale de la RechercheLearn more
Not available based on mandate: 1
Repertoire of human breast and milk microbiota: a systematic review
A Togo, JC Dufour, JC Lagier, G Dubourg, D Raoult, M Million
Future microbiology 14 (7), 623-641, 2019
Available based on mandate: 40
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
P Gautret, JC Lagier, P Parola, L Meddeb, M Mailhe, B Doudier, J Courjon, ...
International journal of antimicrobial agents 56 (1), 105949, 2020
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
CA Devaux, JM Rolain, P Colson, D Raoult
International journal of antimicrobial agents 55 (5), 105938, 2020
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
P Colson, JM Rolain, JC Lagier, P Brouqui, D Raoult
International journal of antimicrobial agents 55 (4), 105932, 2020
Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards
B La Scola, M Le Bideau, J Andreani, VT Hoang, C Grimaldier, P Colson, ...
European Journal of Clinical Microbiology & Infectious Diseases 39 (6), 1059 …, 2020
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
P Gautret, JC Lagier, P Parola, L Meddeb, J Sevestre, M Mailhe, ...
Travel medicine and infectious disease 34, 101663, 2020
Chloroquine for the 2019 novel coronavirus SARS-CoV-2
P Colson, JM Rolain, D Raoult
International journal of antimicrobial agents 55 (3), 105923, 2020
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: a retrospective analysis of 1061 cases in Marseille, France
M Million, JC Lagier, P Gautret, P Colson, PE Fournier, S Amrane, ...
Travel medicine and infectious disease 35, 101738, 2020
ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome
CA Devaux, JM Rolain, D Raoult
Journal of Microbiology, Immunology and Infection 53 (3), 425-435, 2020
Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses
D Raoult, A Zumla, F Locatelli, G Ippolito, G Kroemer
Cell stress 4 (4), 66, 2020
In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect
J Andreani, M Le Bideau, I Duflot, P Jardot, C Rolland, M Boxberger, ...
Microbial pathogenesis 145, 104228, 2020
Bacterial culture through selective and non-selective conditions: the evolution of culture media in clinical microbiology
M Bonnet, JC Lagier, D Raoult, S Khelaifia
New microbes and new infections 34, 100622, 2020
Teicoplanin: an alternative drug for the treatment of COVID-19?
SA Baron, C Devaux, P Colson, D Raoult, JM Rolain
International journal of antimicrobial agents 55 (4), 105944, 2020
Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis
JC Lagier, M Million, P Gautret, P Colson, S Cortaredona, ...
Travel medicine and infectious disease 36, 101791, 2020
Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage
A Fluckiger, R Daillère, M Sassi, BS Sixt, P Liu, F Loos, C Richard, ...
Science 369 (6506), 936-942, 2020
Gut bacteria composition drives primary resistance to cancer immunotherapy in renal cell carcinoma patients
L Derosa, B Routy, M Fidelle, V Iebba, L Alla, E Pasolli, N Segata, ...
European urology 78 (2), 195-206, 2020
Correlation between 3790 quantitative polymerase chain reaction–positives samples and positive cell cultures, including 1941 severe acute respiratory syndrome coronavirus 2 …
R Jaafar, S Aherfi, N Wurtz, C Grimaldier, T Van Hoang, P Colson, ...
Clinical Infectious Diseases 72 (11), e921-e921, 2021
Evaluation of the Panbio Covid-19 rapid antigen detection test device for the screening of patients with Covid-19
F Fenollar, A Bouam, M Ballouche, L Fuster, E Prudent, P Colson, ...
Journal of clinical microbiology 59 (2), 10.1128/jcm. 02589-20, 2021
Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade
G Ferrere, MT Alou, P Liu, AG Goubet, M Fidelle, O Kepp, S Durand, ...
JCI insight 6 (2), 2021
Immune responses during COVID-19 infection
C Melenotte, A Silvin, AG Goubet, I Lahmar, A Dubuisson, A Zumla, ...
Oncoimmunology 9 (1), 1807836, 2020
Publication and funding information is determined automatically by a computer program